Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Theodore M. Johnson II"'
Autor:
Seth Zissette, Moses C. Kiti, Brady W. Bennett, Carol Y. Liu, Kristin N. Nelson, Alana Zelaya, Joseph T. Kellogg, Theodore M. Johnson II, Pam Clayton, Scott K. Fridkin, Saad B. Omer, Benjamin A. Lopman, Carly Adams
Publikováno v:
BMC Research Notes, Vol 16, Iss 1, Pp 1-6 (2023)
Abstract Objective We measured contact patterns using social contact diaries for 157 U.S. long-term care facility employees from December 2020 - June 2021. These data are crucial for analyzing mathematical transmission models and for informing health
Externí odkaz:
https://doaj.org/article/43874ac891b94201b7a6ade75772bc0e
Autor:
David B Rein, Madeleine E Hackney, Yara K Haddad, Farah A Sublett, Briana Moreland, Laurie Imhof, Cora Peterson, Jaswinder K Legha, Janice Mark, Camille P Vaughan, Theodore M Johnson II, Gwen Bergen
Publikováno v:
JMIR Research Protocols, Vol 13, p e54395 (2024)
BackgroundThe Center for Disease Control and Prevention’s Stopping Elderly Accidents, Deaths, and Injuries (STEADI) initiative offers health care providers tools and resources to assist with fall risk screening and multifactorial fall risk assessme
Externí odkaz:
https://doaj.org/article/6e6be5142b504fb6adee0c06d638c9d0
Autor:
Camille P Vaughan, Alayne D Markland, Alison J Huang, Cathy A Alessi, Andrew Guzman, Jennifer L Martin, Donald L Bliwise, Theodore M Johnson II, Kathryn L Burgio, Constance H Fung
Publikováno v:
Age and ageing, vol 51, iss 2
Age Ageing
Age Ageing
Nocturia and chronic insomnia disorder are common conditions that frequently coexist in older adults. Existing medication treatments for each condition have risks, particularly in older adults. While treatment guidelines recommend starting with behav
Autor:
Peter K, Sand, Theodore M, Johnson Ii, Eric S, Rovner, Pamela I, Ellsworth, Michael G, Oefelein, David R, Staskin
Publikováno v:
BJU international. 107(4)
• To evaluate the safety and efficacy of once-daily trospium chloride extended release (ER) in overactive bladder syndrome (OAB) in subjects aged ≥ 75 years.• The analysis included subjects ≥ 75 years of age with OAB. • A subgroup analysis